Medical devices, healthcare technology and the business of care
510(k) clearance · K262149

corra cervical plating system

Carlsmed, Inc. · Decision date Sep 24, 2026

MEDTECHLEDGER EXPLANATIONK262149

What did the FDA decide?

The FDA recorded a substantially equivalent decision dated September 24, 2026 for the corra® cervical plating system submitted by Carlsmed, Inc. under K262149. The device is a Class II spinal intervertebral body fixation orthosis under 21 CFR 888.3060, product code KWQ, intended for anterior cervical fixation from C2 to T1 and for use with the aprevo® cervical interbody system. The submission was dated August 21, 2026 and received August 24, 2026.

The clearance rests on comparison with the primary predicate K260570, also a corra® cervical plating system from the same applicant, covering intended use, technological characteristics and non-clinical testing, including mechanical testing per ASTM F1717 and cadaveric evaluation. The summary states clinical testing was not applicable and that the equivalence determination was not based on clinical performance data. The record does not identify which design, material or labeling elements changed relative to the predicate, and no indications beyond those listed are documented here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 24, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262149
Regulatory pathway
510(k) premarket notification
Product code
KWQ
Decision code
SESE
Decision date
Sep 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Appliance, Fixation, Spinal Intervertebral Body.

Product code
KWQ
FDA device class
2

FDA decision timeline

  1. K262149 received

    Application receipt date recorded by FDA.

  2. K262149 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Carlsmed, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Carlsbad, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records